Ubiquitination of Lysine 867 of the Human SETDB1 Protein Upregulates Its Histone H3 Lysine 9 (H3K9) Methyltransferase Activity-Reference-Cited by-同舟云学术

Ubiquitination of Lysine 867 of the Human SETDB1 Protein Upregulates Its Histone H3 Lysine 9 (H3K9) Methyltransferase Activity

Published:2016-10-31 Issue:10 Volume:11 Page:e0165766
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Ishimoto Kenji,Kawamata Natsuko,Uchihara Yoshie,Okubo Moeka,Fujimoto Reiko,Gotoh Eiko,Kakinouchi Keisuke,Mizohata Eiichi,Hino Nobumasa,Okada Yoshiaki,Mochizuki Yasuhiro,Tanaka Toshiya,Hamakubo Takao,Sakai Juro,Kodama Tatsuhiko,Inoue Tsuyoshi,Tachibana Keisuke,Doi Takefumi

Funder

Japan Society for the Promotion of Science

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference44 articles.

1. Identification and quantification of protein posttranslational modifications;AR Farley;Methods Enzymol,2009

2. Small changes huge impact: the role of protein posttranslational modifications in cellular homeostasis and disease;TM Karve;J Amino Acids,2011

3. O-GlcNAcylation regulates EZH2 protein stability and function;CS Chu;Proc Natl Acad Sci U S A,2014

4. SUV39H1/H3K9me3 attenuates sulforaphane-induced apoptotic signaling in PC3 prostate cancer cells;GW Watson;Oncogenesis,2014

5. Methylation of a histone mimic within the histone methyltransferase G9a regulates protein complex assembly;SC Sampath;Mol Cell,2007

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting the Tumor Epigenetic Regulator SETDB1 for Tumor Therapy;Current Cancer Drug Targets;2024-08-27

2. Changes in Histone Code Regulation during the Initiation of Paraptosis-Like Death of HEp-2 Tumor Cells by Oxidized Disulfiram Derivatives;Biochemistry (Moscow), Supplement Series A: Membrane and Cell Biology;2024-06

3. SETDB1, an H3K9-specific methyltransferase: An attractive epigenetic target to combat cancer;Drug Discovery Today;2024-05

4. SETDB1: Progress and prospects in cancer treatment potential and inhibitor research;Bioorganic Chemistry;2024-04

5. SETDB1 as a cancer target: challenges and perspectives in drug design;RSC Medicinal Chemistry;2024